tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumCompany AnnouncementsMural Oncology Plc Elects Directors at Annual Meeting
3M ago
Premium
Pre-Earnings
MURA Upcoming Earnings Report: What to Expect?
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
Mural Oncology halting progress of nemvaleukin trial in ovarian cancer
PremiumThe FlyMural Oncology halting progress of nemvaleukin trial in ovarian cancer
6M ago
Mural Oncology downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Mural Oncology downgraded to Hold from Buy at JonesResearch
6M ago
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
Premium
The Fly
Mural Oncology downgraded to Outperform from Strong Buy at Raymond James
6M ago
PremiumCompany AnnouncementsMural Oncology Highlights 2024 Financial Results and Strategic Focus
6M ago
Mural Oncology reports Q4 EPS ($2.01), consensus ($1.96)
Premium
The Fly
Mural Oncology reports Q4 EPS ($2.01), consensus ($1.96)
6M ago
Premium
Ratings
Promising Prospects for Mural Oncology: Buy Rating Justified by Strong Pipeline and Financial Position
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100